IMPACT OF LIPID PROFILE IN HYPERGLYCEMIC PATIENTS
Main Article Content
Keywords
Diabetes mellitus, Lipid profile.
Abstract
Introduction- Type 2 diabetes mellitus (T2DM) is a syndrome of abnormal carbohydrate, fat and protein metabolism. T2DM is caused by absolute or relative lack of insulin and is a major public health concern. [1] According to the last International Diabetes Federation (IDF) report, the rate of diabetic patients will reach to 438 million patients worldwide in 2030. [2] Type 2 diabetes can be treated but due to its long-term complications, it causes many risks to health. Prolonged high sugar level in T2DM can affect the immune, cardiovascular, renal and ophthalmic systems, leading to complications like neuropathy, peripheral vascular disease, renal disease, retinopathy and coronary heart disease. Diabetic patients are highly prevalent to cardiovascular disease. [3-4]
Aim- Impact of Lipid Profile in Hyperglycemic patients
Material and Method- This research was conducted on 200 samples from individuals with type 2 diabetes mellitus and controls from medically fit subjects. Patients conducted at Biochemistry department in collaboration with Medicine Department at Index Medical College, Indore.
Result- In this study FBS were found highly significant [<0.0001] in case 222.74±21.01 (Mean±SD) as comparision of healthy person (Mean±SD) 86.44±8.75. TC were found significant [<0.0001] in case 281.23±13.07 (Mean±SD) as comparisons of healthy person 166.17±12.65 (Mean±SD). TG were found significant [<0.0001] in case 359.30±62.54 (Mean±SD) as comparisons of healthy person 115.09±11.55 (Mean±SD). HDL were found significant [<0.0001] in case 28.37±6.13 (Mean±SD) as comparisons of healthy person39.37±4.91(Mean±SD). LDL were found significant [<0.0001] in case 172.37±15.97(Mean±SD) as comparisons of healthy person 105.27±15.80(Mean±SD).
VLDL were found significant [<0.0001] in case 48.85±4.71(Mean±SD) as comparisons of healthy person23.11±2.21(Mean±SD).
Conclusion- Type 2 diabetes mellitus patients, as well as in all patients with unexpected worsening of their lipid profile or vice-versa because our data statistically suggest that the effect of Plasma glucose associated with lipid disorders that are characterized by increased TC, Triglycerides, LDL-C, VLDL-C and decreased HDL-C levels
References
2. Mahdavi SO, Hashemi S, Boostani NS, Zokaee H. Anew method to evaluate fasting plasma glucose by salivary glucose measurement. Iranian Journal of Diabetes and obesity 2016; 4 (3); 127-33.
3. Prathibha K.M., Priscilla J., Mathangi G., Subhashini AS. Evaluation of Salivary Profile among Adult Type 2 Diabetes Mellitus Patients in South India. J Clin Diagn Res. 2014; 7(8): 1592–1595.
4. Sameed A.M., Khatana BS, Tracey H.T., Andrea G.D., and Wen-Chih W. Association between C-reactive protein Levels and Insulin Therapy in Obese vs. Non obese Veterans with Type 2 Diabetes Mellitus. Journal of clinical hypertension. 2015; 12 (6): 452-468.
5. Samatha P, Venkateswarlu M, Siva Prabodh V. Lipid Profile Levels in TypeDiabetes Mellitus from Tribal Population of Adilabad in Andhra Pradesh, INDIA. Journal of clinical and diagnostic research.2015; Vol.6 (4): 590-592.
6. Daniel NAT and Philip AK. Type 2 diabetes mellitus influences lipid profile of diabetic patients. Annals of Biological Research. 2019; 4 (6): 88-92.
7. Popa LM., Popa AR., Dale GF., and Popes. The prediction and assessment of cardiovascular and renal disease in type 2 diabetes. A current review. Rom J Diabetes Nutr Metab Dis. 2017; 20(4): 427-434.
8. Karjalainen S, Sewón L, Söderling E, Larsson B, Johansson I, Simell O, Lapinleimu H, Seppänen R.. Salivary cholesterol of healthy adults in relation to serum cholesterol concentration and oral health. Journal of Dental Research.1997; 76 (10): 1637-43.
9. Ravindran R, Gopinathan DM, Sukumaran S. Estimation of salivary glucose and glycogen content in exfoliated buccal mucosal cells of patients with type II diabetes mellitus. J ClinDiagn Res 2015;9:ZC89-93.
10. Borggreve SE, De Vries R, Dullaart RP. Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin: cholesterol acyltransferase and lipid transfer proteins. Eur J Clin Invest 2023; 33: 1051-1069.
11. Vajo Z, Terry JG, Brinton EA. Increased intra-abdominal fat may lower HDL levels by increasing the fractional catabolic rate of Lp A-I in postmenopausal women. Atherosclerosis 2022; 160: 495-501.
12. Schmitt JK, Poole JR, Lewis SB. Hemoglobin A1 correlates with the ratio of low to high density lipoprotein in normal weight type 2 diabetics. Metabolism 2015; 31: 1084-9.
13. Toth PP. Effective management of the type 2 diabetes patient with cardiovascular and renal disease: secondary prevention strategies after a myocardial infarction. Curr Diabetes Rev 2022; 8(3): 219-28.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Kamini Savita
Ph.D. Scholor, Dept. of Biochemistry, Index Medical College, Hospital & Research Centre, Malwanchal University, Indore, MP India
Jyoti Tomar
Demonstrator, Dept. of Biochemistry, S.N. Medical College, & Hospital, Agra, UP India
Kamna Singh
Associate Professor & Head, Dept. of Biochemistry, S.N. Medical College, & Hospital, Agra, UP India
Naman Yadav
Student, Dept. of Statistics, Amity University, Lucknow, UP India
Aditya Nigoshkar
Demonstrator, Dept. of Biochemistry, Index Medical College, Hospital & Research Centre, Malwanchal University, Indore, MP India
Dr. Shreya Nigoshkar
Professor, Dept. of Biochemistry, Index Medical College, Hospital & Research Centre, Malwanchal University, Indore, MP India